Main Page
Faculty Deanship
Dean
Vice Dean for Graduate Studies and Research
Vice Dean for Female Section
Vice dean for Academic Affairs
Vice Dean, University Hospital Director
Departments
Basic Sciences
Department of Anatomy
Department of Pharmacology
Department of Pathology
Department of Microbiology and Medical Parasitolog
Deparment of Clinical Biochemistry
Department of Physiology
Department of Medical Genetics
Clinical Sciences
Department of Otorhinolaryngology
Department of Obstetrics and Gynecology
Department of Hematology
Department of Medical Education
Department of Anesthesia
Department of Family Medicine
Department of Community Medicine
Department of Surgery
Department of Orthopedic Surgery
Department of ophthalmology
Department of Radiology
Department of Internal Medicine
Department of Pediatrics
Department of Emergency Medicine
Department of Urology
Department of Dermatology
Latest News
Map
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Faculty of Medicine
Document Details
Document Type
:
Article In Journal
Document Title
:
Topiramate for the treatment of infants with early myoclonic encephalopathy
Topiramate for the treatment of infants with early myoclonic encephalopathy
Document Language
:
English
Abstract
:
Objectives: Early myoclonic encephalopathy (EME) is a rare epileptic syndrome characterized by neonatal onset of severe recurrent seizures of multiple types often resistant to antiepileptic drugs (AEDs). Topiramate (TPM) is a new AED, which has a wide spectrum of antiepileptic activities suggesting a potentially valuable therapeutic profile. There is limited clinical data available on TPM use in infants and our aim is to report our experience with TPM for the treatment of infants with intractable seizures secondary to EME. Methods: Prospective, open label, add on trial of TPM in treating a series of infants with EME at King Faisal Specialist Hospital and Research Centre and King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia between June 1999 and March 2002. Topiramate was started at 12.5 mg/day and was increased by doubling the dose every week until the minimum effective dose was reached (seizure free outcome) or up to a maximum of 10 mg/kg/day. Results: Four consecutive infants (2 males and 2 females)were included. In addition to daily seizures, they all had global hypotonia, developmental delay, and progressive microcephaly. The syndrome was cryptogenic in 3, and one had nonketotic hyperglycinemia. Initial electroencephalograms showed generalized epileptic burst suppression pattern. Infants were tried on multiple AEDs (6- 11, mean 7.5) with no success. Topiramate was added at age 5-12 months (mean 9) reaching a maximum dose of 5.5-10 mg/kg/day (mean 7.6). The infants were then followed for up to 19 months (mean 13.5). After introducing TPM, one infant became completely seizure free and 3 had significant (>50%) seizure reduction. Electroencephalograms in 3 infants showed marked improvement. One infant had weight loss that resulted in discontinuing the drug after 6 months. Follow-up renal ultrasound findings were normal in all infants. Conclusions: Topiramate is effective and safe in treating infants with intractable epilepsy secondary to EME
ISSN
:
1658-3183
Journal Name
:
Neurosciences
Volume
:
8
Issue Number
:
2
Publishing Year
:
1424 AH
2003 AD
Article Type
:
Article
Added Date
:
Monday, March 31, 2008
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
محمد جان
Jan, Mohammed
Investigator
Doctorate
mmsjan@yahoo.com
صالح باعيسى
Baeesa, Saleh
Researcher
Doctorate
Files
File Name
Type
Description
Topiramate_for_Early_Myoclonic_Encephalopathy.pdf
pdf
مشاهدة المقالة العلمية كاملة
Back To Researches Page